Trial Profile
VITAL Germany (Valdoxan improves treatment of depression and daytime activity in real life) : an observational prospective multicentre study.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 10 Nov 2013
Price :
$35
*
At a glance
- Drugs Agomelatine (Primary)
- Indications Major depressive disorder
- Focus Adverse reactions; Therapeutic Use
- Acronyms VITAL; VITAL-Germany
- Sponsors Servier
- 01 Apr 2012 Status changed from recruiting to completed as reported by ISRCTN: Current Controlled Trials record.
- 29 Mar 2011 New trial record